It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Although there has been no official Yasmin recall by the United States Food and Drug Administration (FDA), Bayer AG has been notified that their advertising campaigns were misleading regarding side effects. As a result, Bayer AG has been ordered to modify their ad campaigns. The pharmaceutical company must also receive FDA approval before releasing new ad campaigns in the United States. This decision is the result of several class action lawsuits being filed by those affected by undisclosed side effects. At least one of those lawsuits is a federal lawsuit that is alleging that these Yasmin side effects are responsible for several deaths.
TextIf you or a loved one has suffered from any of the harmful side effects of Yaz such as blood clots, stroke or heart attack you may be entitled to file a Yasmin lawsuit against the manufacturer. A lawyer with experience in birth control litigation can help evaluate your claim. Many women around the United States have suffered from life-threatening Yasmin birth control side effects. Unfortunately, most people don’t know that they may have important legal rights.
A doctor may discuss these symptoms with their patient before prescribing Yasmin. However, these side effects are also listed within the documentation that accompanies each package of pills.
But what has not been disclosed is that Yasmin has recently encountered problems that have been linked to even more serious side effects than what are listed above. These side effects include:
Misleading Claims By The Drug Company That Manufactures Yaz
Yaz, Yasmin and Ocella are particularly dangerous because they have been marketed to young women with misleading advertising and false claims. In fact, the Food and Drug Administration (FDA) has sent several letters to Bayer HealthCare Pharmaceuticals, Inc. for what the FDA called "misleading" advertising claims it found "particularly troubling" because they served to "undermine the communication of important risk information, minimizing these risks and misleadingly suggesting that Yaz is safer than has been demonstrated by substantial evidence or substantial clinical experience."
In addition, Yaz, Yasmin and Ocella have been targeted to young women as a means to reduce acne or reduce premenstrual symptoms. In fact, some doctors have prescribed these drugs for non-sexually active girls as an acne fighter alone.
The FDA reprimanded Bayer [in 2008] for overstating the benefits and downplaying the risks of Yaz in television advertisements. The slogan for Yaz was "beyond birth control."
The Food and Drug Administration (FDA) has sent several warning letters to Bayer HealthCare Pharmaceuticals, Inc. for what the FDA termed “misleading” advertising spots it found “particularly troubling” because they served to “undermine the communication of important risk information, minimizing these risks and misleadingly suggesting that Yaz is safer than has been demonstrated by substantial evidence or substantial clinical experience.”